profit from every SEK 100 of sales.
SEK 0SEK 100
Apotea
SEK 105.60+1.25% today
+19.5% in 1 year
1-year low SEK 55.581-year high SEK 105.60
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay SEK 48.05 for every SEK 1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Apotea sold, what it kept, and what it did with the cash.
Sales went from SEK 4.88 billion in 2022 to SEK 7.20 billion in 2025, with SEK 229 million of profit last year.
SalesProfit
Apotea vs. similar companies
Apotea grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from SEK 100 of sales | Sales growth a year | Price per SEK 1 of profit |
|---|---|---|---|
| Apotea | 48.1× · Expensive | ||
 JD Health International | 21.7× · Fair price | ||
 Tsuruha Holdings | 26.5× · Fair price | ||
 MatsukiyoCocokara & | 20.1× · Fair price | ||
 Raia Drogasil | 20.0× · Fair price |
AI analysis
An AI analyst reads Apotea's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of SEK | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 4,883 | 5,450 | 6,541 | 7,203 | |
| 1,271 | 1,449 | 1,788 | 1,938 | |
| 49 | 113 | 263 | 304 | |
| 105 | 226 | 400 | 464 | |
| 20 | 87 | 215 | 229 | |
| 0.19 | 0.84 | 2.09 | 2.20 | |
| 26.0% | 26.6% | 27.3% | 26.9% | |
| 1.0% | 2.1% | 4.0% | 4.2% | |
| 0.4% | 1.6% | 3.3% | 3.2% |
Balance sheet
| In millions of SEK | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 1,253 | 1,336 | 1,628 | 1,981 |
| Cash | 18 | 19 | 27 | 31 |
| Total debt | 333 | 262 | 242 | 331 |
| Total liabilities | 898 | 911 | 992 | 1,121 |
| 328 | 404 | 615 | 844 | |
| 104 | 104 | 103 | 104 | |
| 4.2% | 13.5% | 25.0% | 20.4% | |
| 6.1% | 21.6% | 34.9% | 27.1% |
Cash flow
| In millions of SEK | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 32 | 216 | 206 | 333 | |
| 142 | 121 | 164 | 216 | |
| -111 | 95 | 42 | 118 | |
| Dividends paid | 29 | – | – | – |
| – | – | – | – | |
| – | – | – | – |
Valuation
- 48.1×
- –
- 0.38
- 9.3×
- 1.5×
- 93.4×
- 24.3×
- 1.1%
- 2.1%
- –
Profitability
- 26.9%
- 4.2%
- 3.2%
- –
- 20.4%
- 15.8%
- –
- –
- –
- –
Growth
- +13.8%
- +125.8%
- –
- –
- +0.0%
Financial health
- 0.6×
- 0.39
- –
- 25.2×
- 1.28
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 8%of 948
Bottom 37%of 871
Bottom 24%of 560
Top 41%of 868
Bottom 49%of 985
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
52No pass
Benjamin Graham
38No pass
Philip Fisher
50No pass
Peter Lynch
89Pass
Joel Greenblatt
20No pass
Charlie Munger
42No pass
Terry Smith
36No pass
Questions about Apotea
Is Apotea a good stock to buy?
A business with weak numbers, but the price is high. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Apotea AI analysis
What does Apotea do?
Apotea AB (publ) operates an online pharmacy in Sweden. It is in Pharmaceutical Retailers, based in Stockholm, Sweden, with 744 employees.
Is Apotea stock halal?
Yes. Apotea passes our halal screen: its business is permitted and its debt is 3% of its market value, under the 30% limit. How we check
How has Apotea stock done over the past year?
Up 19.5% over the past twelve months, to SEK 105.60. It traded between SEK 55.58 and SEK 105.60, close to its high.
Who are Apotea's competitors?
The largest listed companies in the same industry are JD Health International, Tsuruha Holdings, MatsukiyoCocokara & and Raia Drogasil. The peers table on this page compares their profit, growth and price with Apotea's.
Prices: daily closes to Nov 9, 2026. Fundamentals: company reports via invest-like data.